Tag: Celldex Therapeutics

Equity Investing

Celldex Therapeutics Inc. (CLDX) Announces Successful Results of Phase 1b Skin-Disorder Drug

Celldex Therapeutics Inc. (NASDAQ: CLDX) announced the results of a clinical trial of its drug that is intended to treat dermatological conditions. This week, Celldex

Catching News are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.

Tag: Celldex Therapeutics

Celldex Therapeutics Inc. (CLDX) Announces Successful Results of Phase 1b Skin-Disorder Drug

Popular Articles

NOVONIX (NVX) Stock Sees Significant Rise Ahead Of Company Update

Surge In Greenland Technologies (GTEC) Shares Signals Market Confidence

Soluna Holdings (SLNH) Soars On Charts After Unveiling Game-Changing Initiative

Important Links